Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Upcoming)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107995

Ethacrynic Acid EFFECTS ON THE COCHLEAR POTENTIALS IN NORMAL AND HIGH BLOOD OXYGEN

Jiri Prazma and John B. Pecorak

1Department of Surgery, Division of Otolaryngology, University of North Carolina, School of Medicine, Chapel Hill, North Carolina 27514

Find articles by Prazma, J. in: JCI | PubMed | Google Scholar

1Department of Surgery, Division of Otolaryngology, University of North Carolina, School of Medicine, Chapel Hill, North Carolina 27514

Find articles by Pecorak, J. in: JCI | PubMed | Google Scholar

Published April 1, 1975 - More info

Published in Volume 55, Issue 4 on April 1, 1975
J Clin Invest. 1975;55(4):840–844. https://doi.org/10.1172/JCI107995.
© 1975 The American Society for Clinical Investigation
Published April 1, 1975 - Version history
View PDF
Abstract

The effect of ethacrynic acid (EA) at different blood O2 saturations on cochlear potentials of guinea pigs was investigated. All 18 young healthy guinea pigs received 50 mg/kg/h of EA intravenously and were divided into three groups: first group, normal (90.00±6.30-86.17±4.83 mm Hg); second group, lower Po2 (78.00±4.74-70.00±4.42 mm Hg); and third group, high Po2 (174.40±13.41-179.00±26.15 mm Hg). The partial pressure of oxygen (Po2), the partial pressure of carbon dioxide (Pco2), and the pH of the blood were measured before EA administration and at the end of the experiment (3 h later) by drawing blood samples from the contralateral carotid artery. Cochlear potentials—endocochlear potential (EP), cochlear microphonics (CM), and action potentials (AP)—were recorded by standard methods from the first turn of the cochlea. Experimental data seem to indicate that elevation of the Po2 to 174-179 mm Hg during relatively high doses of EA treatment prevents the declines in cochlear potentials which were observed in the first and second groups (normal and lower Po2), and preserves active ion transport which is responsible for the generation of cochlear potentials. These data suggest a means by which to reduce the ototoxic effect of EA and possibly indicates a method of treatment for hearing loss which developed after the administration of EA.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 840
page 840
icon of scanned page 841
page 841
icon of scanned page 842
page 842
icon of scanned page 843
page 843
icon of scanned page 844
page 844
Version history
  • Version 1 (April 1, 1975): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts